Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02093559 · ClinicalTrials.gov registry record · NA
Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients
A NA study, sponsored by San Francisco Department of Public Health.
- Completed
- Registry status
- NA
- Development phase
- 63
- Enrollment target
NCT02093559 is a NA study that has completed, run by San Francisco Department of Public Health. The registered enrollment target is 63 participants.
The verdict
NCT02093559, a NA study, has completed, sponsored by San Francisco Department of Public Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 63 participants
- Enrollment target
Study Summary
REBOOT is a pilot randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among naloxone recipients (REBOOT). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the feasibility of an efficacy trial of REBOOT vs treatment as usual (information and referrals) that will evaluate overdose events (non-fatal or death), drug use cessation, and overdose and HIV risk behaviors, among opioid-dependent persons who have previously overdosed and already received take-home naloxone (the opioid antagonist used to reverse overdose).
Interventions
- BEHAVIORAL Brief counseling Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2014-07 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02093559
The ClinicalTrials.gov registry entry for NCT02093559 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is San Francisco Department of Public Health, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Brief counseling Intervention is the first listed.
NCT02093559 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02093559 about?
NCT02093559 is a clinical study titled "Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients". REBOOT is a pilot randomized trial of a repeated-dose brief intervention to reduce overdose and risk behaviors among naloxone recipients (REBOOT). It includes an established overdose education curriculum within an Informational-Motivation-Behavior (IMB) model. This study will test the feasibility of...
What is the current status of trial NCT02093559?
This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2014-07. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02093559?
The interventions under investigation include: Brief counseling Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02093559?
This trial is sponsored by San Francisco Department of Public Health, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.